Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors? V Yazisiz, G Arslan, İH Ozbudak, S Turker, F Erbasan, AB Avci, ... Rheumatology international 30, 1317-1324, 2010 | 145 | 2010 |
Platelet activation in subjects with impaired glucose tolerance E Coban, S Kucuktag, S Basyigit Platelets 18 (8), 591-594, 2007 | 56 | 2007 |
Differential changes in Substance P, VIP as well as neprilysin levels in patients with gastritis or ulcer N Erin, S Türker, Ö Elpek, B Yıldırım Peptides 35 (2), 218-224, 2012 | 28 | 2012 |
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy C Karacin, B Oksuzoglu, A Demirci, M Keskinkılıç, NK Baytemür, F Yılmaz, ... BMC cancer 23 (1), 136, 2023 | 20 | 2023 |
ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer N Erin, S Türker, Ö Elpek, B Yildirim Experimental and therapeutic medicine 15 (2), 1999-2005, 2018 | 14 | 2018 |
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey. B Hacioglu, O Kostek, S Karabulut, D Tastekin, C Alandag, B Akagunduz, ... Journal of BU ON.: official journal of the Balkan Union of Oncology 25 (4 …, 2020 | 11 | 2020 |
The impact of lymph node ratio on overall survival in patients with colorectal cancer Gİ İmamoğlu, A Oğuz, S Cimen, T Eren, C Karacin, D Colak, M Altşbaş, ... Journal of Cancer Research and Therapeutics 17 (4), 1069-1074, 2021 | 10 | 2021 |
The relation between inflammation-based parameters and survival in metastatic pancreatic cancer S Turker, E Cilbir, DC Guven, C Karacin, S Yalcin Journal of Cancer Research and Therapeutics 17 (2), 510-515, 2021 | 10 | 2021 |
The effect of HER2-low status on pathological complete response and survival in triple-negative breast cancer: a systemic review and meta-analysis Y Ergun, B Akagunduz, C Karacin, S Turker, G Ucar Clinical Breast Cancer 23 (6), 567-575, 2023 | 7 | 2023 |
Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment S Turker, E Cilbir, C Karacin, M Altinbas Journal of Cancer Research and Therapeutics 16 (3), 690-692, 2020 | 7 | 2020 |
" Squamos cell lung cancer" case applying with dyspepsia complaints S Turker, H Sahinli, P Perkin, D Yazilitas, NO Koklu, GI Imamoglu, ... Journal of Oncological Sciences 4 (3), 147-148, 2018 | 7 | 2018 |
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer M Gürbüz, E Akkuş, A Sakin, S Urvay, AG Demiray, S Şahin, T Şakalar, ... Tumori Journal 107 (5), 416-423, 2021 | 6 | 2021 |
Tumor‐to‐tumor metastasis: Breast cancer metastasis to lung cancer. S Turker, E Çılbır, KB Yilmaz, E Yetişgin, G İmamoğlu, K İnan, H Şahinli, ... Breast Journal 26 (3), 2020 | 6 | 2020 |
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer SA Esen, Y Ergun, C Erol, R Arikan, MM Er, MM Atci, A Topçu, G Uçar, ... Bosnian journal of basic medical sciences 22 (5), 818, 2022 | 4 | 2022 |
Worse patient–physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology … A Alkan, A Yaşar, ZG Güç, M Gürbüz, T Başoğlu, S Sezgin Göksu, ... European Journal of Cancer Care 29 (6), e13296, 2020 | 4 | 2020 |
Predictors of neoplasia in colonic wall thickening detected via computerized tomography C Karacin, S Türker, T Eren, GI Imamoglu, K Yılmaz, Y Coskun, SO Gunes, ... Cureus 12 (9), 2020 | 4 | 2020 |
The mean platelet volume to lymphocyte ratio: a new prognostic marker in resected gastric cancer H Şahinli, S Türker, T Eren, E Cilbir, M ALTINBAŞ EJMI 4, 155-160, 2020 | 4 | 2020 |
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study O Avcı, Y İriağaç, E Çavdar, K Karaboyun, M Araz, T Şakalar, E Değerli, ... Journal of Geriatric Oncology 14 (8), 101604, 2023 | 3 | 2023 |
Trastuzumab±Capecitabine maintenance after the first-line treatment of HER2-positive advanced gastric cancer: retrospective observational real-life data of Turkish Oncology Group M Gürbüz, E Akkuş, A Sakin, S Urvay, AG Demiray, S Şahin, T Şakalar, ... Journal of Gastrointestinal Cancer 53 (2), 282-288, 2022 | 3 | 2022 |
Real-life analysis of efficacy and safety of everolimus plus exemestane in hormone receptor-positive, human epidermal growth factor receptor-2-negative metastatic breast cancer … A Bilici, M Uysal, S Menekse, S Akin, F Yildiz, M Turan, S Sezgin Goksu, ... Cancer Investigation 40 (2), 199-209, 2022 | 3 | 2022 |